CN Stock MarketDetailed Quotes

600062 China Resources Double-Crane Pharmaceutical

Watchlist
  • 19.56
  • +1.04+5.62%
Market Closed Aug 23 15:00 CST
20.33BMarket Cap14.58P/E (TTM)

China Resources Double-Crane Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
1.46%5.93B
2.26%2.84B
6.20%10.22B
5.42%7.55B
18.99%5.84B
10.11%2.77B
5.64%9.63B
4.11%7.16B
6.07%4.91B
4.59%2.52B
Operating revenue
1.46%5.93B
2.26%2.84B
6.20%10.22B
5.42%7.55B
18.99%5.84B
10.11%2.77B
5.64%9.63B
4.11%7.16B
6.07%4.91B
4.59%2.52B
Other operating revenue
-40.28%44.6M
----
5.23%108.38M
----
23.35%74.69M
----
32.24%102.99M
----
80.22%60.55M
----
Total operating cost
2.82%4.9B
1.37%2.35B
5.12%8.71B
5.44%6.3B
18.32%4.77B
10.22%2.31B
3.14%8.28B
2.14%5.97B
2.41%4.03B
2.12%2.1B
Operating cost
-0.19%2.46B
-0.27%1.23B
6.71%4.58B
5.69%3.37B
15.58%2.47B
12.48%1.23B
6.41%4.29B
9.95%3.19B
10.05%2.13B
11.51%1.09B
Operating tax surcharges
3.06%75.33M
8.45%34.23M
10.01%132.8M
13.39%95.61M
22.51%73.1M
2.69%31.56M
4.29%120.72M
-4.18%84.32M
-2.22%59.66M
3.33%30.74M
Operating expense
1.94%1.56B
3.30%741.56M
-1.80%2.68B
-2.18%1.84B
16.76%1.54B
0.03%717.88M
-2.61%2.73B
-8.27%1.88B
-7.83%1.31B
-10.07%717.67M
Administration expense
8.33%494.95M
-0.76%226.4M
5.64%794.51M
14.12%646.19M
27.25%456.91M
25.39%228.13M
6.84%752.09M
-0.33%566.26M
5.19%359.06M
-1.55%181.93M
Financial expense
15.70%-24.41M
-169.69%-13.67M
54.23%-43.84M
49.01%-32.11M
9.51%-28.96M
38.07%-5.07M
-159.49%-95.79M
-168.43%-62.97M
-122.41%-32.01M
10.75%-8.18M
-Interest expense (Financial expense)
-22.26%6.55M
-9.62%3.16M
32.42%14.07M
195.84%10.96M
86.12%8.43M
67.29%3.49M
-8.60%10.62M
-57.38%3.7M
-19.22%4.53M
-25.52%2.09M
-Interest Income (Financial expense)
5.01%-27.57M
-37.92%-15.89M
40.98%-52.93M
34.11%-35.04M
-8.10%-29.02M
5.33%-11.52M
-64.76%-89.68M
-48.23%-53.18M
-15.06%-26.85M
-5.29%-12.17M
Research and development
24.34%328.65M
17.06%130.33M
16.37%561.46M
19.65%379.52M
36.61%264.32M
33.29%111.34M
17.80%482.48M
19.07%317.2M
7.24%193.49M
16.50%83.53M
Credit Impairment Loss
100.96%239.48K
-39.04%-23.62M
27.11%-1.73M
20.36%-19.21M
9.15%-25.02M
-3.76%-16.99M
-84.19%-2.37M
-52.53%-24.12M
-53.49%-27.54M
3.35%-16.37M
Asset Impairment Loss
1,559.06%10M
709.40%3.46M
-440.55%-101.7M
-405.42%-22.37M
74.43%-685.62K
127.33%427.85K
71.16%-18.81M
-52.65%-4.43M
-0.37%-2.68M
-41.60%-1.57M
Other net revenue
106.41%141.55M
25.16%4.13M
-102.14%-1.78M
-52.11%26.48M
91.42%68.58M
-31.00%3.3M
51.14%83.28M
-16.25%55.3M
8.82%35.83M
-22.98%4.78M
Fair value change income
----
----
130.45%13.8M
2,416.81%11.01M
2,148.38%6.98M
-51.83%2.85M
-83.06%5.99M
-98.41%437.52K
-101.57%-340.63K
-8.01%5.92M
Invest income
70.01%79.94M
227.68%12.77M
-22.69%12.55M
-78.75%5.65M
132.69%47.02M
4,348.54%3.9M
-40.14%16.23M
111.90%26.57M
697.13%20.21M
-29.31%87.59K
-Including: Investment income associates
----
227.68%12.77M
-22.69%12.55M
-78.75%5.65M
----
4,348.54%3.9M
3.82%16.23M
111.90%26.57M
697.13%20.21M
-29.31%87.59K
Asset deal income
128.06%2.04M
-52.71%319.75K
97.53%-56.13K
114.63%364.52K
-57.32%895.9K
169.81%676.15K
-320.00%-2.27M
-155.60%-2.49M
45.87%2.1M
-204.14%-968.54K
Other revenue
25.21%49.32M
-9.96%11.2M
-10.85%75.35M
-13.98%51.04M
-10.65%39.39M
-29.67%12.44M
45.43%84.52M
47.77%59.34M
57.91%44.08M
5.47%17.68M
Operating profit
2.12%1.17B
6.87%494.44M
6.16%1.52B
2.72%1.27B
24.76%1.15B
9.11%462.64M
25.52%1.43B
13.43%1.24B
25.88%918.72M
18.28%424.02M
Add:Non operating Income
19.64%33.28M
980.80%18.77M
133.88%71.06M
41.33%28M
81.64%27.82M
234.57%1.74M
617.61%30.38M
214.03%19.81M
272.82%15.31M
-84.04%519.16K
Less:Non operating expense
-14.71%5.83M
87.42%2.8M
-13.09%19.57M
-26.20%11.98M
-37.71%6.84M
-70.45%1.49M
12.62%22.52M
194.44%16.24M
202.14%10.98M
310.39%5.05M
Total profit
2.63%1.2B
10.27%510.42M
9.17%1.57B
3.71%1.29B
26.45%1.17B
10.35%462.88M
27.98%1.43B
13.68%1.24B
26.39%923.06M
16.36%419.49M
Less:Income tax cost
-15.02%144.4M
32.87%105.71M
19.55%240.61M
-2.33%216.69M
9.40%169.93M
7.32%79.56M
35.03%201.27M
30.66%221.86M
44.17%155.33M
17.01%74.13M
Net profit
5.64%1.05B
5.58%404.71M
7.48%1.33B
5.02%1.07B
29.90%997.27M
11.00%383.33M
26.90%1.23B
10.56%1.02B
23.31%767.73M
16.22%345.36M
Net profit from continuing operation
5.64%1.05B
5.58%404.71M
7.48%1.33B
5.02%1.07B
29.90%997.27M
11.00%383.33M
26.90%1.23B
10.56%1.02B
23.31%767.73M
16.22%345.36M
Less:Minority Profit
-44.33%7M
-234.83%-11.4M
-113.29%-7.12M
-110.83%-4.67M
-59.54%12.58M
-36.85%8.45M
47.04%53.59M
22.50%43.09M
11.03%31.09M
22.21%13.39M
Net profit of parent company owners
6.28%1.05B
11.00%416.11M
12.96%1.33B
10.12%1.08B
33.67%984.69M
12.92%374.88M
26.12%1.18B
10.08%978.68M
23.89%736.64M
15.99%331.97M
Earning per share
Basic earning per share
6.35%1.0199
11.01%0.4075
14.09%1.3002
10.15%1.0502
33.96%0.959
15.37%0.3671
27.06%1.1396
11.88%0.9534
25.60%0.7159
16.00%0.3182
Diluted earning per share
6.35%1.0199
10.93%0.405
14.09%1.3002
11.03%1.0502
33.96%0.959
14.74%0.3651
27.06%1.1396
11.00%0.9459
25.60%0.7159
16.00%0.3182
Other composite income
-100.85%-781.09
-101.53%-1.32K
-41.41%858.64K
719.17%91.3K
1,698.87%92.05K
16,679.61%86.31K
120.94%1.47M
886.13%11.15K
380.46%5.12K
-1,313.03%-520.56
Other composite income of parent company owners
-100.85%-781.09
-101.53%-1.32K
-53.18%858.44K
719.17%91.3K
1,698.87%92.05K
16,679.61%86.31K
128.00%1.83M
886.13%11.15K
380.46%5.12K
-1,313.03%-520.56
Other composite income of minority owners
----
----
100.06%205.24
----
----
----
18.19%-367.98K
----
----
----
Total composite income
5.63%1.05B
5.55%404.71M
7.42%1.33B
5.03%1.07B
29.91%997.36M
11.02%383.42M
27.97%1.24B
10.56%1.02B
23.31%767.73M
16.22%345.36M
Total composite income of parent company owners
6.27%1.05B
10.97%416.11M
12.86%1.33B
10.13%1.08B
33.69%984.78M
12.95%374.96M
27.20%1.18B
10.08%978.69M
23.89%736.64M
15.99%331.97M
Total composite income of minority owners
-44.33%7M
-234.83%-11.4M
-113.38%-7.12M
-110.83%-4.67M
-59.54%12.58M
-36.85%8.45M
47.85%53.22M
22.50%43.09M
11.03%31.09M
22.21%13.39M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
KPMG Huazhen Certified Public Accountants (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 1.46%5.93B2.26%2.84B6.20%10.22B5.42%7.55B18.99%5.84B10.11%2.77B5.64%9.63B4.11%7.16B6.07%4.91B4.59%2.52B
Operating revenue 1.46%5.93B2.26%2.84B6.20%10.22B5.42%7.55B18.99%5.84B10.11%2.77B5.64%9.63B4.11%7.16B6.07%4.91B4.59%2.52B
Other operating revenue -40.28%44.6M----5.23%108.38M----23.35%74.69M----32.24%102.99M----80.22%60.55M----
Total operating cost 2.82%4.9B1.37%2.35B5.12%8.71B5.44%6.3B18.32%4.77B10.22%2.31B3.14%8.28B2.14%5.97B2.41%4.03B2.12%2.1B
Operating cost -0.19%2.46B-0.27%1.23B6.71%4.58B5.69%3.37B15.58%2.47B12.48%1.23B6.41%4.29B9.95%3.19B10.05%2.13B11.51%1.09B
Operating tax surcharges 3.06%75.33M8.45%34.23M10.01%132.8M13.39%95.61M22.51%73.1M2.69%31.56M4.29%120.72M-4.18%84.32M-2.22%59.66M3.33%30.74M
Operating expense 1.94%1.56B3.30%741.56M-1.80%2.68B-2.18%1.84B16.76%1.54B0.03%717.88M-2.61%2.73B-8.27%1.88B-7.83%1.31B-10.07%717.67M
Administration expense 8.33%494.95M-0.76%226.4M5.64%794.51M14.12%646.19M27.25%456.91M25.39%228.13M6.84%752.09M-0.33%566.26M5.19%359.06M-1.55%181.93M
Financial expense 15.70%-24.41M-169.69%-13.67M54.23%-43.84M49.01%-32.11M9.51%-28.96M38.07%-5.07M-159.49%-95.79M-168.43%-62.97M-122.41%-32.01M10.75%-8.18M
-Interest expense (Financial expense) -22.26%6.55M-9.62%3.16M32.42%14.07M195.84%10.96M86.12%8.43M67.29%3.49M-8.60%10.62M-57.38%3.7M-19.22%4.53M-25.52%2.09M
-Interest Income (Financial expense) 5.01%-27.57M-37.92%-15.89M40.98%-52.93M34.11%-35.04M-8.10%-29.02M5.33%-11.52M-64.76%-89.68M-48.23%-53.18M-15.06%-26.85M-5.29%-12.17M
Research and development 24.34%328.65M17.06%130.33M16.37%561.46M19.65%379.52M36.61%264.32M33.29%111.34M17.80%482.48M19.07%317.2M7.24%193.49M16.50%83.53M
Credit Impairment Loss 100.96%239.48K-39.04%-23.62M27.11%-1.73M20.36%-19.21M9.15%-25.02M-3.76%-16.99M-84.19%-2.37M-52.53%-24.12M-53.49%-27.54M3.35%-16.37M
Asset Impairment Loss 1,559.06%10M709.40%3.46M-440.55%-101.7M-405.42%-22.37M74.43%-685.62K127.33%427.85K71.16%-18.81M-52.65%-4.43M-0.37%-2.68M-41.60%-1.57M
Other net revenue 106.41%141.55M25.16%4.13M-102.14%-1.78M-52.11%26.48M91.42%68.58M-31.00%3.3M51.14%83.28M-16.25%55.3M8.82%35.83M-22.98%4.78M
Fair value change income --------130.45%13.8M2,416.81%11.01M2,148.38%6.98M-51.83%2.85M-83.06%5.99M-98.41%437.52K-101.57%-340.63K-8.01%5.92M
Invest income 70.01%79.94M227.68%12.77M-22.69%12.55M-78.75%5.65M132.69%47.02M4,348.54%3.9M-40.14%16.23M111.90%26.57M697.13%20.21M-29.31%87.59K
-Including: Investment income associates ----227.68%12.77M-22.69%12.55M-78.75%5.65M----4,348.54%3.9M3.82%16.23M111.90%26.57M697.13%20.21M-29.31%87.59K
Asset deal income 128.06%2.04M-52.71%319.75K97.53%-56.13K114.63%364.52K-57.32%895.9K169.81%676.15K-320.00%-2.27M-155.60%-2.49M45.87%2.1M-204.14%-968.54K
Other revenue 25.21%49.32M-9.96%11.2M-10.85%75.35M-13.98%51.04M-10.65%39.39M-29.67%12.44M45.43%84.52M47.77%59.34M57.91%44.08M5.47%17.68M
Operating profit 2.12%1.17B6.87%494.44M6.16%1.52B2.72%1.27B24.76%1.15B9.11%462.64M25.52%1.43B13.43%1.24B25.88%918.72M18.28%424.02M
Add:Non operating Income 19.64%33.28M980.80%18.77M133.88%71.06M41.33%28M81.64%27.82M234.57%1.74M617.61%30.38M214.03%19.81M272.82%15.31M-84.04%519.16K
Less:Non operating expense -14.71%5.83M87.42%2.8M-13.09%19.57M-26.20%11.98M-37.71%6.84M-70.45%1.49M12.62%22.52M194.44%16.24M202.14%10.98M310.39%5.05M
Total profit 2.63%1.2B10.27%510.42M9.17%1.57B3.71%1.29B26.45%1.17B10.35%462.88M27.98%1.43B13.68%1.24B26.39%923.06M16.36%419.49M
Less:Income tax cost -15.02%144.4M32.87%105.71M19.55%240.61M-2.33%216.69M9.40%169.93M7.32%79.56M35.03%201.27M30.66%221.86M44.17%155.33M17.01%74.13M
Net profit 5.64%1.05B5.58%404.71M7.48%1.33B5.02%1.07B29.90%997.27M11.00%383.33M26.90%1.23B10.56%1.02B23.31%767.73M16.22%345.36M
Net profit from continuing operation 5.64%1.05B5.58%404.71M7.48%1.33B5.02%1.07B29.90%997.27M11.00%383.33M26.90%1.23B10.56%1.02B23.31%767.73M16.22%345.36M
Less:Minority Profit -44.33%7M-234.83%-11.4M-113.29%-7.12M-110.83%-4.67M-59.54%12.58M-36.85%8.45M47.04%53.59M22.50%43.09M11.03%31.09M22.21%13.39M
Net profit of parent company owners 6.28%1.05B11.00%416.11M12.96%1.33B10.12%1.08B33.67%984.69M12.92%374.88M26.12%1.18B10.08%978.68M23.89%736.64M15.99%331.97M
Earning per share
Basic earning per share 6.35%1.019911.01%0.407514.09%1.300210.15%1.050233.96%0.95915.37%0.367127.06%1.139611.88%0.953425.60%0.715916.00%0.3182
Diluted earning per share 6.35%1.019910.93%0.40514.09%1.300211.03%1.050233.96%0.95914.74%0.365127.06%1.139611.00%0.945925.60%0.715916.00%0.3182
Other composite income -100.85%-781.09-101.53%-1.32K-41.41%858.64K719.17%91.3K1,698.87%92.05K16,679.61%86.31K120.94%1.47M886.13%11.15K380.46%5.12K-1,313.03%-520.56
Other composite income of parent company owners -100.85%-781.09-101.53%-1.32K-53.18%858.44K719.17%91.3K1,698.87%92.05K16,679.61%86.31K128.00%1.83M886.13%11.15K380.46%5.12K-1,313.03%-520.56
Other composite income of minority owners --------100.06%205.24------------18.19%-367.98K------------
Total composite income 5.63%1.05B5.55%404.71M7.42%1.33B5.03%1.07B29.91%997.36M11.02%383.42M27.97%1.24B10.56%1.02B23.31%767.73M16.22%345.36M
Total composite income of parent company owners 6.27%1.05B10.97%416.11M12.86%1.33B10.13%1.08B33.69%984.78M12.95%374.96M27.20%1.18B10.08%978.69M23.89%736.64M15.99%331.97M
Total composite income of minority owners -44.33%7M-234.83%-11.4M-113.38%-7.12M-110.83%-4.67M-59.54%12.58M-36.85%8.45M47.85%53.22M22.50%43.09M11.03%31.09M22.21%13.39M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----KPMG Huazhen Certified Public Accountants (Special General Partnership)------Ernst & Young (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg